In corresponding studies of candesartan therapy in subjects with both type 1 and type 2 diabetes who had retinopathy at baseline, the drug failed to mitigate retinopathy progression.

• 在相应的1型和2型糖尿病视网膜病变坎地沙坦治疗研究中，该药物却不能减轻视网膜病变的进展。